Literature DB >> 18486949

Non-canonical binding of an antibody resembling a naïve B cell receptor immunoglobulin to hepatitis B virus capsids.

Norman R Watts1, Giovanni Cardone, Joe G Vethanayagam, Naiqian Cheng, Catharina Hultgren, Stephen J Stahl, Alasdair C Steven, Matti Sällberg, Paul T Wingfield.   

Abstract

The hepatitis B virus capsid (core antigen) is able to bind to and activate naïve B cells and these become efficient primary antigen-presenting cells for the priming of T cells. We have investigated this interaction by using cryo-electron microscopy, three-dimensional image reconstruction, and molecular modeling to visualize capsids decorated with Fab fragments of a receptor immunoglobulin, and surface plasmon resonance to measure the binding affinity. By both criteria, the mode of binding differs from those of the six monoclonal anti-core antigen antibodies previously characterized. The Fab interacts with two sites approximately 30 A apart. One interaction is canonical, whereby the CDR loops engage the tip of one of the 25 A spikes that protrude from the capsid surface. The second interaction is non-canonical; in it, the Fab framework contacts the tip of an adjacent spike. The binding affinity of this Fab for capsids, K(D) approximately 4 x 10(-7) M, is relatively low for an antibody-antigen interaction, but is approximately 150-fold lower still ( approximately 2.5 x 10(-5) M) for unassembled capsid protein dimers. The latter observation indicates that both of the observed interactions are required to achieve stable binding of capsids by this receptor immunoglobulin. Considerations of conserved sequence motifs in other such molecules suggest that other naïve B cells may interact with HBV capsids in much the same way.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486949      PMCID: PMC2474722          DOI: 10.1016/j.jmb.2008.04.009

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  44 in total

Review 1.  Evolution of isotype switching.

Authors:  Janet Stavnezer; Chris T Amemiya
Journal:  Semin Immunol       Date:  2004-08       Impact factor: 11.130

2.  Software extensions to UCSF chimera for interactive visualization of large molecular assemblies.

Authors:  Thomas D Goddard; Conrad C Huang; Thomas E Ferrin
Journal:  Structure       Date:  2005-03       Impact factor: 5.006

3.  Epitope diversity of hepatitis B virus capsids: quasi-equivalent variations in spike epitopes and binding of different antibodies to the same epitope.

Authors:  A Harris; D M Belnap; N R Watts; J F Conway; N Cheng; S J Stahl; J G Vethanayagam; P T Wingfield; A C Steven
Journal:  J Mol Biol       Date:  2005-11-08       Impact factor: 5.469

4.  Structure, assembly, and antigenicity of hepatitis B virus capsid proteins.

Authors:  Alasdair C Steven; James F Conway; Naiqian Cheng; Norman R Watts; David M Belnap; Audray Harris; Stephen J Stahl; Paul T Wingfield
Journal:  Adv Virus Res       Date:  2005       Impact factor: 9.937

Review 5.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 6.  Confounding B-cell defences: lessons from a staphylococcal superantigen.

Authors:  Gregg J Silverman; Carl S Goodyear
Journal:  Nat Rev Immunol       Date:  2006-06       Impact factor: 53.106

Review 7.  Similarity and divergence in the development and expression of the mouse and human antibody repertoires.

Authors:  Harry W Schroeder
Journal:  Dev Comp Immunol       Date:  2006       Impact factor: 3.636

8.  Hepatitis core antigen produced in Escherichia coli: subunit composition, conformational analysis, and in vitro capsid assembly.

Authors:  P T Wingfield; S J Stahl; R W Williams; A C Steven
Journal:  Biochemistry       Date:  1995-04-18       Impact factor: 3.162

9.  A structural model for maturation of the hepatitis B virus core.

Authors:  Alan M Roseman; John A Berriman; Samantha A Wynne; P Jonathan G Butler; R Anthony Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-24       Impact factor: 11.205

10.  Clathrin-mediated endocytosis and lysosomal cleavage of hepatitis B virus capsid-like core particles.

Authors:  Arik Cooper; Yosef Shaul
Journal:  J Biol Chem       Date:  2006-04-17       Impact factor: 5.157

View more
  8 in total

1.  Interaction of the hepatitis B core antigen and the innate immune system.

Authors:  Byung O Lee; Amy Tucker; Lars Frelin; Matti Sallberg; Joyce Jones; Cory Peters; Janice Hughes; David Whitacre; Bryan Darsow; Darrell L Peterson; David R Milich
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

2.  Sizing up large protein complexes by electrospray ionisation-based electrophoretic mobility and native mass spectrometry: morphology selective binding of Fabs to hepatitis B virus capsids.

Authors:  Jessica Z Bereszczak; Marlene Havlik; Victor U Weiss; Martina Marchetti-Deschmann; Esther van Duijn; Norman R Watts; Paul T Wingfield; Guenter Allmaier; Alasdair C Steven; Albert J R Heck
Journal:  Anal Bioanal Chem       Date:  2013-12-20       Impact factor: 4.142

3.  Cryo-EM study of Hepatitis B virus core antigen capsids decorated with antibodies from a human patient.

Authors:  Eaazhisai Kandiah; Norman R Watts; Naiqian Cheng; Giovanni Cardone; Stephen J Stahl; Theo Heller; T Jake Liang; Paul T Wingfield; Alasdair C Steven
Journal:  J Struct Biol       Date:  2011-10-25       Impact factor: 2.867

4.  Molecular basis for the high degree of antigenic cross-reactivity between hepatitis B virus capsids (HBcAg) and dimeric capsid-related protein (HBeAg): insights into the enigmatic nature of the e-antigen.

Authors:  Norman R Watts; Joe G Vethanayagam; R Bridget Ferns; Richard S Tedder; Audray Harris; Stephen J Stahl; Alasdair C Steven; Paul T Wingfield
Journal:  J Mol Biol       Date:  2010-03-20       Impact factor: 5.469

5.  Specificity of an anti-capsid antibody associated with Hepatitis B Virus-related acute liver failure.

Authors:  Weimin Wu; Zhaochun Chen; Naiqian Cheng; Norman R Watts; Stephen J Stahl; Patrizia Farci; Robert H Purcell; Paul T Wingfield; Alasdair C Steven
Journal:  J Struct Biol       Date:  2012-10-16       Impact factor: 2.867

6.  Epitope-distal effects accompany the binding of two distinct antibodies to hepatitis B virus capsids.

Authors:  Jessica Z Bereszczak; Rebecca J Rose; Esther van Duijn; Norman R Watts; Paul T Wingfield; Alasdair C Steven; Albert J R Heck
Journal:  J Am Chem Soc       Date:  2013-04-18       Impact factor: 15.419

7.  Structure of a patient-derived antibody in complex with allergen reveals simultaneous conventional and superantigen-like recognition.

Authors:  Alkistis N Mitropoulou; Holly Bowen; Tihomir S Dodev; Anna M Davies; Heather J Bax; Rebecca L Beavil; Andrew J Beavil; Hannah J Gould; Louisa K James; Brian J Sutton
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-27       Impact factor: 11.205

Review 8.  Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV.

Authors:  Thomas Vanwolleghem; Tom Adomati; Stijn Van Hees; Harry L A Janssen
Journal:  JHEP Rep       Date:  2021-11-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.